Updated Jul 16, 2026
Goldan Keith A. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $149K.

Keith A. Goldan is the Chief Financial Officer of Syndax Pharmaceuticals Inc, a clinical-stage biopharmaceutical company focused on developing therapies for various cancer indications. He has been involved in multiple SEC filings related to the company's financial activities.
| Role | Insider |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-02 | SNDX | Syndax Pharmaceuticals Inc | S — Open-market sale | 1.2K | $18.99 | $22K |
| 2026-04-07 | ABEO | ABEONA THERAPEUTICS INC. | A — Grant or award | 32.8K | $0.00 | |
| 2026-02-10 | SNDX | Syndax Pharmaceuticals Inc | S — Open-market sale | 3.4K | $21.03 | $72K |
| 2026-02-06 | SNDX | Syndax Pharmaceuticals Inc | S — Open-market sale | 2.1K | $20.62 | $43K |
| 2026-02-06 | SNDX | Syndax Pharmaceuticals Inc | A — Grant or award | 30.8K | $0.00 | |
| 2026-02-06 | SNDX | Syndax Pharmaceuticals Inc | A — Grant or award | 21.5K | $0.00 | |
| 2026-02-06 | SNDX | Syndax Pharmaceuticals Inc | J — Other acquisition / disposition | 1.2K | $8.48 | $10K |
| 2025-12-01 | SNDX | Syndax Pharmaceuticals Inc | G — Bona-fide gift | 1.2K | $0.00 | |
| 2025-07-31 | SNDX | Syndax Pharmaceuticals Inc | J — Other acquisition / disposition | 1.2K | $8.43 | $10K |
| 2025-07-16 | SNDX | Syndax Pharmaceuticals Inc | S — Open-market sale | 1.3K | $9.29 | $12K |
Keith A. Goldan is the Chief Financial Officer of Syndax Pharmaceuticals Inc, a clinical-stage biopharmaceutical company focused on developing therapies for various cancer indications. He has been involved in multiple SEC filings related to the company's financial activities.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 4 open-market sales ($149K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Goldan Keith A. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.